None listed
Conditions
Interventions
Medical Device : During hospitalization, participants will wear MEMO Patch M, a single-lead wearable ECG patch, for 12 hours to up to 8 days. A 24-hour Holter monitor will also be performed during hos
Sponsors
Asan Medical Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Adults aged 19 years or older who voluntarily provide written informed consent to participate in the study 2) Patients diagnosed with ESUS (Embolic Stroke of Undetermined Source) 3) Patients who require in-hospital or out-of-hospital electrocardiographic (ECG) monitoring
Exclusion criteria
Exclusion criteria: 1) Individuals already diagnosed with atrial fibrillation or atrial flutter 2) Individuals with a clearly identified cause of stroke 3) Individuals known to have allergic reactions to adhesives or hydrogels 4) Individuals who, in the investigator’s judgment, have cognitive vulnerability that makes it difficult to understand the study information and voluntarily decide on participation 5) Any other individuals whom the principal investigator considers to be at potential risk by participating in the study or otherwise unsuitable for participation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Detection rate of Atrial Fibrillation (%) | — |
Secondary
| Measure | Time frame |
|---|---|
| Time of Atrial Fibrillation (AF) detection;Accuracy of in-hospital monitoring alarms; AF detection rate and burden during out-of-hospital MEMO Patch2 monitoring;Detection rate of non-AF arrhythmias;Analysis of arrhythmia types including AF;Risk factor analysis for AF occurrence;Rate and timing of treatment strategy changes (Including medication and procedures) after AF diagnosis;Comparison of AF detection rates and timing between two monitoring strategies (MEMO Patch M + MEMO Patch2 vs. Holter + ILR) | — |
Countries
Korea, Republic of
Contacts
Public ContactYunJeong In
Asan Medical Center
Outcome results
None listed